Loading
Tumour cells injected into transparent fish embryos grow in days, so several drugs can be compared in about a week, fast enough to help a patient who cannot wait.
Zebrafish patient-derived xenografts accept small cell numbers, are transparent for direct imaging of growth and metastasis, and give readouts in five to ten days at a fraction of mouse cost. Studies in colorectal and other cancers report concordance with patient outcomes. They lack an adaptive immune system and drug metabolism differs, so their role is rapid triage rather than definitive prediction.
Shares Estimation of clinical trial success rates and related parameters, Patient-derived xenografts, Lab models that fail to predict what happens in patients, Pancreatic ductal adenocarcinoma.
Shares Estimation of clinical trial success rates and related parameters, Functional (ex vivo) drug testing, Lab models that fail to predict what happens in patients.
Shares Estimation of clinical trial success rates and related parameters, Patient-derived xenografts, Lab models that fail to predict what happens in patients.
Shares Estimation of clinical trial success rates and related parameters, Patient-derived xenografts, Lab models that fail to predict what happens in patients.
Shares Estimation of clinical trial success rates and related parameters, Patient-derived xenografts, Lab models that fail to predict what happens in patients.
Shares Estimation of clinical trial success rates and related parameters, Functional (ex vivo) drug testing, Lab models that fail to predict what happens in patients.
Shares Estimation of clinical trial success rates and related parameters, Patient-derived xenografts, Functional (ex vivo) drug testing, Lab models that fail to predict what happens in patients.
Shares Estimation of clinical trial success rates and related parameters, Lab models that fail to predict what happens in patients, Colorectal cancer.